Project Grant U1355158
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $9.4M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Scottsdale, AZ, USA
Similar Awards
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $739,562 to the Mayo Clinic to conduct research on the epigenetic regulation of donor heart preservation mediated by the BRD4 protein. The goal is to expand the molecular understanding of cardiac preservation to improve outcomes for heart transplantation. Key aspects of the project include: Determining how factors like cold perfusion and expression of...
- This federal Project Grant award, valued at $695,997.00 and awarded on Aug 18, 2025, supports research conducted by Mayo Clinic Arizona under the Cardiovascular Diseases Research program (CFDA 93.837) administered by the National Heart, Lung, and Blood Institute. The research aims to investigate the role of the Programmed Cell Death 4 (PDCD4) gene in mitigating doxorubicin-induced cardiotoxicity, a common side effect of anthracycline chemotherapy drugs. The project utilizes a juvenile mouse...
- The Defense Health Agency awarded a $736,006 Project Grant to the Mayo Clinic in Rochester, MN to conduct a Phase 1 clinical trial of a biologically engineered growing heart conduit for the repair of discontinuous pulmonary arteries. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The clinical trial will develop an...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,291,419.00 to Mayo Clinic Arizona to conduct a Phase 1 clinical trial using autologous, MUC1-activated T cells expanded from peripheral blood in patients with relapsed and resistant ovarian cancer. The award period runs from September 1, 2024 to August 31, 2028. This research aims to advance innovative cellular immunotherapy approaches to transform...
- The Defense Health Agency awarded a $408,467 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, for a research project titled "METABOLIC REPROGRAMMING OF CAR MACROPHAGES FOR OVARIAN CANCER IMMUNOTHERAPY." The award period runs from September 1, 2023, to August 31, 2025, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project aims to study the metabolic reprogramming of chimeric antigen receptor (CAR) macrophages to...
- The Defense Health Agency awarded a $152,192 Project Grant to Mayo Clinic in Rochester, MN under the Military Medical Research and Development program (CFDA 12.420) to develop a novel approach for the noninvasive molecular classification of kidney cancer using tumor-derived extracellular vesicles. The grant, with a performance period from November 1, 2025 to October 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- This federal Project Grant award of $2,881,926.00 was made on February 1, 2025 by the Office of Naval Research, which administers the Basic and Applied Scientific Research federal grant program (CFDA 12.300). The grant supports the "Development of Medical Technology for Contingency Response to Marrow Toxic Substance" for the National Marrow Donor Program, doing business as Be The Match. This non-profit organization operates the world's largest bone marrow registry and provides...
- This federal Project Grant award of $424,565.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the Mayo Clinic in Rochester, Minnesota. The research aims to investigate the clinical significance of somatic genetic variants in telomere biology disorders. This grant, with a performance period from September 1, 2025 to August 31, 2028, contributes to the Defense Health Agency's broader...
- This federal Project Grant award of $5,690,704.00 from the Health Resources and Services Administration (HRSA) was made under the HIV Care Formula Grants program (CFDA 93.917). The purpose of this grant is to enable the Minnesota Department of Human Services (MN DHS) to improve the quality, availability, and organization of a comprehensive continuum of HIV healthcare, treatment, and support services for eligible low-income individuals living with HIV/AIDS in Minnesota. Key services to be...
- This $322,800 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by Mayo Clinic to investigate the role of osteoprotegerin as a mediator of post-traumatic osteoarthritis through a novel etiopathophysiological mechanism. The research project aims to advance scientific understanding and develop new treatments for this condition, which is particularly relevant for...